DMT-2'-O-MOE-I-CE phosphoramidite
DMT-2'-O-MOE-I-CE phosphoramidite - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.PR6-002
-
SMILESO=C1C2=C(N([C@H]3[C@H](OCCOC)[C@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](COC(C4=CC=CC=C4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1
-
Molecular FormulaC43H53N6O9P
-
Molecular Weight828.90
-
AppearanceReport result
-
PurityUPLC≥97%
-
Storage Condition-20℃
Documentation
Documentation
-
Catalog No.PR6-002
-
SMILESO=C1C2=C(N([C@H]3[C@H](OCCOC)[C@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](COC(C4=CC=CC=C4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=CN1
-
Molecular FormulaC43H53N6O9P
-
Molecular Weight828.90
-
AppearanceReport result
-
PurityUPLC≥97%
-
Storage Condition-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
